The most common side effect of the new insomnia drug, Belsomra, is next day sleepiness, and it has similar risks to that of other sleep aids. In this video, sleep expert Michael Breus, PhD, explains how to minimize the risks of the medication.
Michael J. Breus, PhD, is a clinical psychologist and a fellow of the American Academy of Sleep Medicine. He specializes in sleep disorders and is one of only 163 psychologists in the world with his credentials and distinction.
View Profile